BiotechTube
Home/Shanton Pharma/Bing Li, Ph.D.
BL

Bing Li, Ph.D.

Chief Executive Officer

Shanton Pharma

Therapeutic Areas

GoutHyperuricemiaPruritus

Shanton Pharma Pipeline

DrugIndicationPhase
SAP-001Refractory/Tophaceous GoutPhase 2

Leadership Team at Shanton Pharma

WM
Wenfeng Miao, M.D., Ph.D.
Chief Medical Officer
PD
Pieter de Ridder, MBA
VP of Business Development
SC
Shanshan Cui, Ph.D.
VP of Clinical Development
CA
Carmen Arencibia
Director of Clinical Operations
View full Shanton Pharma profile